Marvisi, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.083
AS - Asia 3.377
EU - Europa 1.972
SA - Sud America 448
Continente sconosciuto - Info sul continente non disponibili 73
AF - Africa 68
OC - Oceania 15
Totale 10.036
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.940
SG - Singapore 1.099
CN - Cina 989
IT - Italia 741
HK - Hong Kong 357
BR - Brasile 352
VN - Vietnam 312
DE - Germania 226
GB - Regno Unito 220
FI - Finlandia 193
BD - Bangladesh 187
KR - Corea 157
RU - Federazione Russa 124
SE - Svezia 100
FR - Francia 97
CA - Canada 78
NL - Olanda 55
IN - India 45
ID - Indonesia 44
IE - Irlanda 40
AR - Argentina 34
AT - Austria 31
MX - Messico 30
IQ - Iraq 29
JP - Giappone 27
LT - Lituania 22
TR - Turchia 21
MA - Marocco 20
PL - Polonia 20
BG - Bulgaria 19
CL - Cile 16
UA - Ucraina 16
AU - Australia 14
PK - Pakistan 13
PT - Portogallo 13
EC - Ecuador 12
ES - Italia 12
KW - Kuwait 12
ZA - Sudafrica 12
AE - Emirati Arabi Uniti 10
CR - Costa Rica 9
DZ - Algeria 9
SA - Arabia Saudita 9
UZ - Uzbekistan 9
PE - Perù 8
TW - Taiwan 8
CO - Colombia 7
CZ - Repubblica Ceca 7
KE - Kenya 7
MY - Malesia 7
PH - Filippine 7
VE - Venezuela 7
IL - Israele 6
TH - Thailandia 6
AZ - Azerbaigian 5
CH - Svizzera 5
GR - Grecia 5
JM - Giamaica 5
AL - Albania 4
EG - Egitto 4
LB - Libano 4
PY - Paraguay 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
BE - Belgio 3
BS - Bahamas 3
KG - Kirghizistan 3
LV - Lettonia 3
MT - Malta 3
RS - Serbia 3
SV - El Salvador 3
AG - Antigua e Barbuda 2
AM - Armenia 2
EE - Estonia 2
ET - Etiopia 2
GY - Guiana 2
KZ - Kazakistan 2
NI - Nicaragua 2
SN - Senegal 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
IM - Isola di Man 1
JO - Giordania 1
KH - Cambogia 1
KY - Cayman, isole 1
Totale 9.950
Salva come PNG Salva come JPEG
Città #
Santa Clara 715
Singapore 680
Ashburn 504
Hefei 503
San Jose 433
Hong Kong 351
Council Bluffs 200
Helsinki 168
Seoul 155
London 134
Munich 130
Beijing 123
Milan 106
Ho Chi Minh City 104
Chandler 101
Los Angeles 99
The Dalles 88
Fairfield 81
Hanoi 69
Dallas 67
New York 66
Nyköping 64
Chicago 59
Moscow 50
Lauterbourg 49
Rome 43
Buffalo 41
Dublin 37
Bologna 36
São Paulo 35
Jakarta 34
Houston 32
Seattle 32
San Diego 29
Shanghai 29
Kent 28
Nuremberg 28
Cambridge 27
Salt Lake City 27
Boardman 26
Wilmington 26
Naples 23
Woodbridge 23
Frankfurt am Main 22
Atlanta 21
Orem 19
Modena 18
Toronto 18
Brooklyn 17
Haiphong 17
Phoenix 17
Portsmouth 17
Redondo Beach 17
Rio de Janeiro 17
Tokyo 17
Amsterdam 16
Princeton 15
Columbus 14
Bremen 13
Florence 13
Lappeenranta 13
North Bergen 13
Vienna 13
Kuwait City 12
Montreal 12
Tampa 12
Turin 12
Boston 11
Da Nang 11
Denver 11
Elk Grove Village 11
Reggio Emilia 11
Santiago 11
Sofia 11
Lawrenceville 10
Mexico City 10
San Francisco 10
Ankara 9
Brasília 9
Manchester 9
Melbourne 9
Tashkent 9
Turku 9
Warsaw 9
Washington 9
Ann Arbor 8
Baghdad 8
Bari 8
Chennai 8
Des Moines 8
Indianapolis 8
Ksawerów 8
Lancaster 8
Padova 8
Parma 8
Philadelphia 8
Brescia 7
Campinas 7
Casablanca 7
Charlotte 7
Totale 6.325
Salva come PNG Salva come JPEG
Nome #
VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis 358
Ultrasound Examination of Common Carotid Adventitial Thickness Can Differentiate Takayasu Arteritis and Large Vessel Giant Cell Arteritis 331
EULAR guidelines on ANCA-associated vasculitis in the real life 291
Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study 253
Effectiveness of Infliximab and Interferon Alpha-2a for the Treatment of Behçet’s Uveitis: Customizing Therapy according to the Clinical Features 243
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 232
Effectiveness and safety of a 26-week taper regimen of glucocorticoid in GCA patients: Results from a prospective cohort study 218
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 218
Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: A population-based study 215
Management of Systemic Sclerosis Patients in the COVID-19 Era: The Experience of an Expert Specialist Reference Center 213
Chronic periaortitis presenting with isolated pulmonary artery involvement: description of two cases 209
Vessel inflammation and morphological changes in patients with large vessel vasculitis: A retrospective study 208
Elevated NET, Calprotectin, and Neopterin Levels Discriminate between Disease Activity in COVID-19, as Evidenced by Need for Hospitalization among Patients in Northern Italy 203
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis 199
New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group 198
The role of sacro-iliac joint magnetic resonance imaging in the diagnosis of axial spondyloarthritis: focus on differential diagnosis in women 194
Prevalence and distribution of vascular calcifications at CT scan in patients with and without large vessel vasculitis: A matched cross-sectional study 187
EVALUATION OF INTERNAL CONSISTENCY, FEASIBILITY, AND RELIABILITY OF THE ITALIAN VERSION OF ANCA-ASSOCIATED VASCULITIS PATIENT-REPORTED OUTCOME (AAV-PRO_ITA) QUESTIONNAIRE: PRELIMINARY RESULTS FROM A MULTICENTER STUDY ON A LARGE COHORT OF ITALIAN PATIENTS 187
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 187
EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 186
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study 183
Senescent cells in giant cell arteritis display an inflammatory phenotype participating in tissue injury via IL-6-dependent pathways 181
Identification of two autoantigens recognised by circulating autoantibodies as potential biomarkers for diagnosing giant cell arteritis 176
Development of the Takayasu Arteritis Integrated Disease Activity Index 171
What to Know About Biopsy Sampling and Pathology in Vasculitis? 170
Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases 170
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 169
Effects in soluble immune checkpoints induced by Tocilizumab monotherapy after ultra-short-term glucocorticoids in large vessel – giant cell arteritis patients 168
Steroid-sparing agents in polymyalgia rheumatica: how will they fit into the treatment paradigm? 167
117. PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG– STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 165
354. EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 165
Tofacitinib for the treatment of refractory Takayasu's arteritis: description of 2 cases 158
Clinical and Prognostic Significance of Serum IgG4 in Chronic Periaortitis. An Analysis of 113 Patients 155
C-reactive protein gene polymorphisms influence susceptibility and outcomes of biopsy-proven giant cell arteritis in Italian patients 154
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis 154
Eosinophilic giant cell arteritis: A different subset of disease? 154
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 153
Aortitis and periaortitis: The puzzling spectrum of inflammatory aortic diseases 152
The management of large vessel vasculitides 150
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study 148
Comparing treatment options for large vessel vasculitis 147
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 145
Trattamento con Tocilizumab in monoterapia dopo trattamento con glucocorticoidi per breve periodo in pazienti con arterite a cellule giganti con coinvolgimento dei grandi vasi: effetti sui checkpoint immunitari solubili 143
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 138
Pros and cons of TNF inhibitors and tocilizumab in the treatment of large-vessel vasculitis 138
Comment on: Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study. Reply 133
The Role of PET in the Diagnosis and Disease Activity Assessment in Large Vessel Vasculitis 132
Systemic vasculitis: one year in review 2024 131
Reply 128
Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease 122
Manifestations of Skull Base IgG4‐Related Disease: A Multi‐Institutional Study 116
Vasculitis, fibromuscular dysplasia or hereditary aneurysms? 112
Reply to Comment on: Vasculitis, fibromuscular dysplasia or hereditary aneurysms? by Marvisi et al 100
PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG-STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 98
The geographic and clinical clusters of Behçet’s syndrome 97
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors 83
Hypereosinophilia and eosinophilic arterial aneurysm: not only eosinophilic granulomatosis with polyangiitis 73
Utilità clinica dell'imaging nell'arterite gigantocellulare 61
The influence of baseline aortitis on aortic dilation risk in GCA: a multicentre imaging study 56
Is immunotherapy safe and effective in patients with VEXAS syndrome? 46
Exploring total inflammatory vascular volume as a diagnostic and prognostic biomarker in giant cell arteritis 44
Totale 10.036
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.372
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.372
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022203 0 0 0 8 11 23 10 13 23 19 46 50
2022/2023483 35 47 28 20 69 51 33 52 60 22 38 28
2023/2024499 14 28 13 62 47 59 65 54 17 33 55 52
2024/20252.752 45 22 89 170 518 449 281 89 327 146 334 282
2025/20264.792 415 260 444 523 543 251 612 193 497 370 378 306
2026/20271.103 172 333 317 281 0 0 0 0 0 0 0 0
Totale 10.036